Regrow’s goal is to improve the Indian health care scenario, aiming to provide proven and advanced cell therapy technology for intractable diseases with its focus on regenerative medicine. We are the first Make in India company in Cell Therapy Technology Regrow has dedicated its focus on biotechnology from its foundation in year 2009 and with its state-of-the-art platform technology has led to the development and approval of India world’s first autologous bone and cartilage; cell therapy product – CHONDRON ® & OSSRON ® Biotechnology and in particular, cell-based therapeutics is considered to be the pivotal and new growth engine to lead the future economy of India. Regrow recognizes the national and public expectations in the field in India and continue to drive our efforts to achieve commercial breakthrough solutions for the unmet needs of industry through the revolutionary cell therapy technology. We sincerely thank you for your trust, encouragement and support and we will continue to devote ourselves to strengthen Regrow as the global leader in the field of biotechnology and regenerative medicine. ‘Some natural resources are finite and cannot be replaced. In the human body, the same could be said about cartilage and bone’